ANL
Adlai Nortye Group Ltd. - American Depositary Shares (ANL)
$57
About Adlai Nortye Group Ltd. - American Depositary Shares (ANL)
Adlai Nortye Group Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.
Details
Daily high
$16.16
Daily low
$15.04
Price at open
$15.99
52 Week High
$17.25
52 Week Low
$0.88
Market cap
924.5M
Dividend yield
-
Volume
92,590
Avg. volume
177,592
P/E ratio
-28.99
Adlai Nortye Group Ltd. - American Depositary Shares News
Details
Daily high
$16.16
Daily low
$15.04
Price at open
$15.99
52 Week High
$17.25
52 Week Low
$0.88
Market cap
924.5M
Dividend yield
-
Volume
92,590
Avg. volume
177,592
P/E ratio
-28.99